npj Gut and Liver

Featured

Patients with ulcerative colitis who have normalized histology are clinically stable after de-escalation of therapy

Shintaro Akiyama
Joëlle St-Pierre
David T. Rubin
ArticleOpen Access02 Aug 2024
Improving immunotherapy for the treatment of hepatocellular carcinoma: learning from patients and preclinical models

Romain Desert
Fabio Gianonne
Thomas F. Baumert
ReviewOpen Access03 Apr 2025
Distinct age-related characteristics in patients with irritable bowel syndrome: patient reported outcomes and measures of gut physiology

Joost P. Algera
Amanda Blomsten
Hans Törnblom
ArticleOpen Access05 Nov 2024
Reviewing MAESTRO-NASH and the implications for hepatology and health systems in implementation/accessibility of Resmetirom

Paul N. Brennan
Christopher J. Kopka
Jeffrey V. Lazarus
PerspectiveOpen Access22 Jan 2025

Announcements

npj Gut and Liver is officially indexed in DOAJ!

We're excited to share that npj Gut and Liver is officially indexed in DOAJ.
The immune cells landscape in the gut-liver axis

Call for Papers: this collection aims to bring together groundbreaking research on the complex immunological interplay within the gut-liver crosstalk in the context of health and disease. Read more...

Open for submissions
Call for Applications: Commissioning & Trainee Editor

We are looking for two Early Career Researchers (for each topical area of the journal) to join the editorial team of npj Gut and Liver in a new, one-year role as Commissioning & Trainee Associate Editor. Read more...
Interested in joining the Editorial Team?

If you are interested in joining the journal as an Editorial Board Member, please complete this Google form.

Browse articles

MicroRNA in intestinal tight junction regulation

Manmeet Rawat
Prem Kumar Govindappa
Thomas Y. Ma
ReviewOpen Access05 May 2025
Steatotic liver disease is a marker of multimorbidity, not underlying cirrhosis, in older adults

O. Oduwole
C. Ding
A. Britton
ArticleOpen Access05 May 2025
Scores to predict steatotic liver disease – correlates and outcomes in older adults

Daniel Clayton-Chubb
Isabella Commins
William W. Kemp
ArticleOpen Access19 Apr 2025
Improving immunotherapy for the treatment of hepatocellular carcinoma: learning from patients and preclinical models

Romain Desert
Fabio Gianonne
Thomas F. Baumert
ReviewOpen Access03 Apr 2025
Statins exposure and adverse events in participants with chronic viral hepatitis: a meta-analysis based on cohort studies

Jiale Ruan
Yingying Fang
Jian Song
ArticleOpen Access25 Mar 2025
The burden of digestive diseases in Asian countries and territories from 1990 to 2019: an analysis for the Global Burden of Disease 2019 study

Qi Chen
Xiaohong Wang
Xiaowei Tang
ArticleOpen Access24 Mar 2025
Clostridioides difficile infection induces a pro-inflammatory and pro-steatotic metabolic state in liver

Farnaz Yousefi
Brett Sponseller
Shankumar Mooyottu
ArticleOpen Access04 Mar 2025
Unlocking therapeutic potential of amlexanox in MASH with insights into bile acid metabolism and microbiome

Wenjing You
Jianfei Ji
Peng Zhao
ArticleOpen Access01 Feb 2025
Reviewing MAESTRO-NASH and the implications for hepatology and health systems in implementation/accessibility of Resmetirom

Paul N. Brennan
Christopher J. Kopka
Jeffrey V. Lazarus
PerspectiveOpen Access22 Jan 2025

Collections

The immune cells landscape in the gut-liver axis

This collection aims at covering the role of innate and adaptive immune cells in the bidirectional relationship between the liver, gut and microbiome during homeostasis and disease.

Collection 14 Nov 2024

Open for submissions

Unlocking therapeutic potential of amlexanox in MASH with insights into bile acid metabolism and microbiome

Featured

Patients with ulcerative colitis who have normalized histology are clinically stable after de-escalation of therapy

Improving immunotherapy for the treatment of hepatocellular carcinoma: learning from patients and preclinical models

Distinct age-related characteristics in patients with irritable bowel syndrome: patient reported outcomes and measures of gut physiology

Reviewing MAESTRO-NASH and the implications for hepatology and health systems in implementation/accessibility of Resmetirom

Announcements

npj Gut and Liver is officially indexed in DOAJ!

The immune cells landscape in the gut-liver axis

Call for Applications: Commissioning & Trainee Editor

Interested in joining the Editorial Team?

Browse articles

MicroRNA in intestinal tight junction regulation

Steatotic liver disease is a marker of multimorbidity, not underlying cirrhosis, in older adults

Scores to predict steatotic liver disease – correlates and outcomes in older adults

Improving immunotherapy for the treatment of hepatocellular carcinoma: learning from patients and preclinical models

Statins exposure and adverse events in participants with chronic viral hepatitis: a meta-analysis based on cohort studies

The burden of digestive diseases in Asian countries and territories from 1990 to 2019: an analysis for the Global Burden of Disease 2019 study

Clostridioides difficile infection induces a pro-inflammatory and pro-steatotic metabolic state in liver

Unlocking therapeutic potential of amlexanox in MASH with insights into bile acid metabolism and microbiome

Reviewing MAESTRO-NASH and the implications for hepatology and health systems in implementation/accessibility of Resmetirom

Collections

The immune cells landscape in the gut-liver axis

Trending - Altmetric

Search

Quick links

Featured

Announcements

Advertisement

Trending - Altmetric

Steatotic liver disease is a marker of multimorbidity, not underlying cirrhosis, in older adults

Search

Quick links